Xenon Pharmaceuticals· Xenon Pharmaceuticals Inc. News Releases·· 29 天前重要性评分0
X-TOLE 开放标签扩展研究：XEN1101 长期癫痫无发作特征分析
Characterization of Long-Term Seizure Freedom in the Ongoing Open-Label Extension of X-TOLE: Potential Implications for Future Clinical Practice
AI 导读
Xenon Pharmaceuticals 公布 X-TOLE 开放标签扩展研究中 XEN1101 长期癫痫无发作的特征分析，探讨其对未来临床实践的潜在意义。该分析基于正在进行的开放标签扩展研究，具体数据未在标题中披露。
正文
Breadcrumb
- Home
- Investors
- News & Events
- Press Releases
- Characterization of Long-Term Seizure Freedom in the Ongoing Open-Label Extension of X-TOLE: Potential Implications for Future Clinical Practice
Investors
News & Events
(Common Stock)
Minimum 15 minutes delayed. Source: LSEG
Email alerts
来源：Xenon Pharmaceuticals · investor.xenon-pharma.com